Sanar is a company.
Sanar has raised $12.0M across 1 funding round.
Key people at Sanar.
Sanar has raised $12.0M in total across 1 funding round.
Key people at Sanar.
Sanar has raised $12.0M in total across 1 funding round.
Sanar's investors include DNA Capital, monashees, Qualcomm Ventures, Redpoint eventures, Noah Pickholtz.
Sanar is a Brazilian edtech company headquartered in Bahia, providing a digital ecosystem of products and services for medical students, healthcare professionals, and related fields, from undergraduate to postgraduate levels.[1][2] It evolved from a traditional book publisher into a leading online platform offering scalable educational tools like streaming content and apps, delivered up to 10x cheaper than traditional methods via an agile, collaborative approach.[2] Sanar serves healthcare learners and practitioners by integrating knowledge with computing applications to enhance performance and work dynamics, with strong growth including a 28% revenue increase to $25.8 million in Q2 2025.[2] As a Certified B Corporation since March 2019 with an 84.7 B Impact Score, it emphasizes governance, ethics, and minimal environmental footprint in education services.[1]
Sanar originated as a traditional book publisher ("Editora Sanar") before rapidly transforming into a digital healthcare education platform within just five years.[2] Based in Bahia, Brazil, it now operates as an IT services and consulting firm with 501-1000 employees, focusing on online tools for medical and health professionals.[2] Key pivotal moments include its B Corp certification in 2019, reflecting a commitment to social and environmental impact, and recent revenue surges signaling market traction in digital education.[1][2] While specific founders are not detailed in available sources, the company's evolution highlights a shift to agile, tech-driven solutions amid rising demand for accessible healthcare training.[2]
(Note: A separate entity named Sanar in the Middle East appears as an MOH-licensed medical platform for primary care and therapy, but primary sources confirm the Brazilian edtech as the core match.[3])
Sanar rides the global edtech wave in healthcare education, accelerated by digital transformation post-pandemic and demand for affordable, accessible training in emerging markets like Brazil.[2] Its timing aligns with rising needs for upskilled medical professionals amid aging populations and healthcare digitization, where traditional publishing fails to scale.[1][2] Market forces favoring Sanar include Brazil's expanding healthtech sector, cost pressures on education, and B Corp appeal to impact-conscious investors—evidenced by ties to firms like DNA Capital.[4] By influencing the ecosystem through cheaper, behavior-integrated tools, Sanar democratizes medical knowledge, potentially reducing barriers for professionals in underserved areas and fostering a collaborative healthtech community.[2]
Sanar's trajectory points to further dominance in Latin American healthtech ed, with revenue momentum and B Corp status positioning it for global expansion or acquisitions by larger players. Trends like AI-personalized learning and telemedicine integration will amplify its platform, while sustained growth could solidify its role as a startup ecosystem enabler. As it scales from publisher to digital leader, expect heightened influence in affordable, impactful education—echoing its core mission to empower healthcare's next generation.
Sanar has raised $12.0M across 1 funding round. Most recently, it raised $12.0M Series B in April 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2020 | $12.0M Series B | DNA Capital, monashees, Qualcomm Ventures, Redpoint eventures, Noah Pickholtz |
